Nambiar, Arjun K.Arlandis, SalvadorBø, KariCobussen-Boekhorst, HannyCostantini, Elisabettade Heide, MonicaFarag, FawzyGroen, JanKaravitakis, MarkosLapitan, Marie CarmelaManso, MargaridaArteaga, Serenella MonagasRiogh, Aisling Nic AnO'Connor, EabhannOmar, Muhammad ImranPeyronnet, BenoitPhé, VeroniqueSakalis, Vasileios I.Sihra, NéhaTzelves, Lazarosvan Poelgeest-Pomfret, Mary Lynnevan den Bos, Tine W.L.van der Vaart, HuubHarding, Christopher K.2023-02-232023-02-232022-07Nambiar, A K, Arlandis, S, Bø, K, Cobussen-Boekhorst, H, Costantini, E, de Heide, M, Farag, F, Groen, J, Karavitakis, M, Lapitan, M C, Manso, M, Arteaga, S M, Riogh, A N A, O'Connor, E, Omar, M I, Peyronnet, B, Phé, V, Sakalis, V I, Sihra, N, Tzelves, L, van Poelgeest-Pomfret, M L, van den Bos, T W L, van der Vaart, H & Harding, C K 2022, 'European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1 : Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence', European Urology, vol. 82, no. 1, pp. 49-59. https://doi.org/10.1016/j.eururo.2022.01.0450302-2838ORCID: /0000-0002-1597-3126/work/112135193https://hdl.handle.net/2164/20143Funding Information: Financial disclosures: Arjun K. Nambiar certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Christopher K. Harding is a company consultant for Teleflex Medical; has received speaker honoraria from Astellas, Allergan, and Medtronic; has participated in clinical trials by Medtronic; has received fellowship and travel grants from Medtronic; and has received research support from the National Institute for Health Research and The Urological Foundation. Marie Carmela Lapitan has received speaker honoraria from Astellas, AstraZeneca, and GSK. Salvador Arlandis has received company speaker honoraria from Astellas Pharma S.A., Bayer Hispania S.L., and Lacer-Holliste; has received honoraria for consultation from Presurgy S.L., Boston Scientific Europe, and Coloplast Productos Medicos; has participated in clinical trials by GlaxoSmithKline, Astellas, Ipsen, and Urovant; has received travel grants from Astellas Pharma S.A., WellSpect, Lacer, and Rovi; and was a company consultant for Lacer Laboratories. Elisabetta Costantini has received research support from S&R Farmaceutici. Jan Groen has participated in clinical trials by Neuspera Medical Inc. Veronique Phé has received speaker honoraria from Medtronic and Viatris and is a company consultant for Allergan and Coloplast. Huub van der Vaart has ownership of a patent with Ligalli B.V., is a director of Berman Clinics, receives royalties from NVOG, is participating in clinical trials by UroGyn, and receives research support from ZonMw and NWO-TTW. Benoit Peyronnet is a company consultant for Boston Scientific. Lazaros Tzelves receives research support from the National and Kapodistrian University of Athens and the ASCAPE Project and is participating in a clinical trial by the ASCAPE Project and received. The remaining authors have nothing to disclose.11346011engFemale lower urinary tracts symptomsdiagnosticsoveractive bladderurinary incontinencestress urinary incontinencemixed urinary incontinenceconservative managementpharmacologic managementsurgical managementEAU GuidelinesR MedicineUrologyRJournal article10.1016/j.eururo.2022.01.045http://www.scopus.com/inward/record.url?scp=85125126549&partnerID=8YFLogxK821